Heartflow’s (NASDAQ:HTFL – Get Free Report) lock-up period is set to end on Wednesday, February 4th. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th. TFC Financial Management Inc. bought a new stake in shares of Heartflow in the third quarter valued at about $40,000. Heartflow Company Profile(Get Free Report)HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease.